[시장보고서]요실금 관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 요실금 부위별, 최종 용도별, 백 용도별, 지역별, 부문별 예측(2025-2030년)

요실금 관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 요실금 부위별, 최종 용도별, 백 용도별, 지역별, 부문별 예측(2025-2030년)

Continence Care Market Size, Share & Trends Analysis Report By Product (Urinary Catheters & Catheter Maintenance/Care), By Application (Diabetes, Strokes), By Areas Of Incontinence, By End-use, By Bag Usage, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1587422

리서치사 : Grand View Research

발행일 : 2024년 10월

페이지 정보 : 영문 221 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

요실금 관리 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계 요실금 관리 시장 규모는 2030년까지 303억 4,000만 달러에 달할 것으로 예상되며, 2025-2030년 CAGR은 7.49%에 달할 것으로 예상됩니다.

대장암, 방광암, 뇌졸중, 당뇨병 등 다양한 만성질환의 유병률 증가. 기술 발전, 다양한 의료 및 재택 의료 현장에서 무균 제품에 대한 수요 증가, 라이프스타일 변화, 노인 인구의 증가가 시장 성장의 주요 요인입니다.

고혈압과 당뇨병의 유병률 증가는 요실금(UI)을 유발하는 주요 요인 중 하나이며, 전 세계적으로 요실금 관리 제품에 대한 수요를 주도하고 있습니다. 예를 들어, 세계보건기구(WHO)가 2023년에 발표한 보고서에 따르면, 전 세계적으로 약 12억 8,000만 명이 고혈압을 앓고 있습니다. 이에 따라 관련 질환을 앓고 있는 환자가 증가함에 따라 요실금 관리 제품에 대한 수요가 급증할 것으로 예상됩니다.

미국 요실금 관리 산업에서 사업을 전개하고 있는 기업으로는 Coloplast, Hollister Incorporated, Convatech Group 등이 있습니다. 이들 기업은 다양한 제품과 소모품을 제공하며 제품 품질, 가격, 혁신성, 유통망 등의 요인에 따라 경쟁하고 있습니다.

요실금 관리 시장 보고서 하이라이트

제품별로는 요실금 및 장 관리 부문이 2024년 약 50.27%의 가장 큰 시장 점유율을 차지했습니다. 남성용 체외 카테터, 여성용 요실금 기기, 경항문 관류 시스템 등의 제품은 이러한 증상을 관리하는 데 효과적이기 때문에 큰 수요를 목격하고 있습니다.
용도별로는 당뇨병 부문이 2024년 27.94%의 점유율을 차지하며 시장을 장악했습니다.
백 용도별로는 무균 백이 감염 및 기타 문제를 피하는 데 필수적이기 때문에 무균 백 부문이 2024년 시장을 장악하고 예측 기간 동안 강력한 성장을 보일 것으로 예상됩니다.
재택 간호를 위한 요실금 관리 제품에 대한 수요 증가와 환자 중심 의료 서비스로 인해 2024년 재택 간호 현장 부문은 전체 최종사용자 시장의 44.68%를 차지했습니다.
유럽은 크론병과 궤양성 대장염의 높은 유병률로 인해 2024년 38.11%의 가장 높은 매출 점유율로 세계 시장을 장악했으며, Journal of Crohn's and Colitis에 따르면 유럽 전체 인구의 0.3%가 IBD를 앓고 있다고 합니다.

지역 대시보드
시장 규모, 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
- 벨기에
- 네덜란드
- 아일랜드
- 그리스
- 폴란드
- 스위스
- 오스트리아
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제10장 경쟁 상황

시장 진출 기업 분류
주요 시장 진출 기업의 최근 동향과 영향 분석
기업 시장 점유율 분석, 2024년
주요 기업 개요
- Coloplast Group
- B. Braun SE
- Hollister Incorporated
- ConvaTec Group Plc
- BD(Becton, Dickinson and Company)
- Wellspect HealthCare
- Salts Healthcare Ltd.
- Welland Medical Ltd.
- Essity Aktiebolag

ksm

영문 목차

영문목차

Continence Care Market Growth & Trends:

The global continence care market size is anticipated to reach USD 30.34 billion by 2030, with a CAGR of 7.49% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing prevalence of various chronic disorders such as colorectal & bladder cancer, strokes, and diabetes. Growing technological advancements, increasing demand for sterile products in various healthcare and homecare settings, and changes in lifestyles, coupled with the rise in the geriatric population are key contributors to the market growth.

The rising prevalence of hypertension and diabetes is one of the major factors causing Urinary Incontinence (UI), driving the demand for continence care products globally. For instance, according to a report released by the WHO in 2023, approximately 1.28 billion people suffer from hypertension globally. Consequently, the increasing number of patients suffering from associated diseases is expected to surge the demand for continence care products.

Some of the companies operating in the U.S. continence care industry are Coloplast, Hollister Incorporated, and Convatec Group, among others. These companies offer a wide range of products & consumables and compete based on factors such as product quality, pricing, innovation, & distribution networks.

Continence Care Market Report Highlights:

Based on product, the incontinence and bowel management held the largest market share of around 50.27% in 2024. Products such as male external catheters, female incontinence devices, and transanal irrigation systems are witnessing significant demand due to their effectiveness in managing these conditions.
Based on application, the diabetes segment dominated the market in 2024 with a share of 27.94% owing to the globally increasing prevalence of diabetes and diabetes-associated UI.
Based on bag usage, the sterile segment held the dominant market in 2024 and is expected to witness robust growth during the forecast period, as sterile bags are essential for avoiding infections and other problems.
The home care settings segment held 44.68% of the overall end-user market in 2024, owing to an increase in demand for continence care products for home care and patient-centric healthcare services.
Europe dominated the global market with the highest revenue share of 38.11% in 2024, owing to the high incidence rate of Crohn's disease & ulcerative colitis in this region. According to the Journal of Crohn's and Colitis, 0.3% of the total population in Europe suffers from IBD.

Table of Content

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Area of Incontinence
- 1.2.4. Bag Usage
- 1.2.5. End Use
- 1.2.6. Regional Scope
- 1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Continence Care Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing prevalence of Urinary Incontinence (UI)
  - 3.2.1.2. Growing geriatric population
  - 3.2.1.3. Rapid technological advancements
  - 3.2.1.4. Rise in demand for minimally invasive procedures
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI)
3.3. Continence Care Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Continence Care Market: Segment Analysis, By Product, 2018 - 2030 (USD Million and Volume Unit)

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Global Continence Care Market, by Product, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.4.1. Urinary Catheters
  - 4.4.1.1. Urinary Catheters market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.1.2. Intermittent Self-Catheterization (ISC)
    - 4.4.1.2.1. Intermittent Self-Catheterization (ISC) market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.2.2. Standard Catheters
      - 4.4.1.2.2.1. Standard Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.2.3. Premium/Lifestyle Catheters
      - 4.4.1.2.3.1. Premium/Lifestyle Catheters market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.1.3. Indwelling/Foley Catheters
    - 4.4.1.3.1. Indwelling/Foley Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.3.2. Coated Catheters
      - 4.4.1.3.2.1. Coated Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.3.3. Uncoated Catheters
      - 4.4.1.3.3.1. Uncoated Catheters market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.1.4. Intermittent Catheter Sets
    - 4.4.1.4.1. Intermittent Catheter Sets market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.4.2. Female
      - 4.4.1.4.2.1. Female market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.1.4.3. Male
      - 4.4.1.4.3.1. Male market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.1.5. Intermittent Catheters Dry
    - 4.4.1.5.1. Intermittent Catheters Dry market, 2018 - 2030 (USD Million and Volume Unit)
- 4.4.2. Catheter Maintenance/Care
  - 4.4.2.1. Catheter Maintenance/Care market, 2018 - 2030 (USD Million and Volume Unit)
- 4.4.3. Urinary Bags
  - 4.4.3.1. Urinary Bags market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.3.2. Pediatric Urine Bags
    - 4.4.3.2.1. Pediatric Urine Bags market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.3.3. Night (Bed) Bags
    - 4.4.3.3.1. Night (Bed) Bags market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.2. By Usability
    - 4.4.3.3.3. Sterile
      - 4.4.3.3.3.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.4. Non-sterile
      - 4.4.3.3.4.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.5. By Usability
    - 4.4.3.3.6. Sterile
      - 4.4.3.3.6.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.7. Non-sterile
      - 4.4.3.3.7.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.8. By Size
    - 4.4.3.3.9. 250 ml
      - 4.4.3.3.9.1. 250 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.10. 350 ml
      - 4.4.3.3.10.1. 350 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.11. 500 ml
      - 4.4.3.3.11.1. 500 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.12. 1.5 L
      - 4.4.3.3.12.1. 1.5 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.13. 2 L
      - 4.4.3.3.13.1. 2 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.14. 4 L
      - 4.4.3.3.14.1. 4 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.3.15. Others
      - 4.4.3.3.15.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.3.4. Bag Accessories
    - 4.4.3.4.1. Bag Accessories market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.3.5. Leg Urine Bags
    - 4.4.3.5.1. Leg Urine Bags market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.2. By Usability
    - 4.4.3.5.3. Sterile
      - 4.4.3.5.3.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.4. Non-sterile
      - 4.4.3.5.4.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.5. By Size
    - 4.4.3.5.6. 350 ml
      - 4.4.3.5.6.1. 250 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.7. 750 ml
      - 4.4.3.5.7.1. 350 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.8. 500 ml
      - 4.4.3.5.8.1. 500 ml market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.9. 1.5 L
      - 4.4.3.5.9.1. 1.5 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.10. 2 L
      - 4.4.3.5.10.1. 2 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.11. 4 L
      - 4.4.3.5.11.1. 4 L market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.3.5.12. Others
      - 4.4.3.5.12.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
- 4.4.4. Incontinence And Bowel Management
  - 4.4.4.1. Incontinence And Bowel Management market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.4.2. Non-Absorbent
    - 4.4.4.2.1. Non-Absorbent market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.2.2. Male External Catheters Silicone
      - 4.4.4.2.2.1. Male External Catheters Silicone market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.2.3. Female External Catheters
      - 4.4.4.2.3.1. Female External Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.2.4. Female Incontinence Device
      - 4.4.4.2.4.1. Female Incontinence Device market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.2.5. Irrigation Pump/Transanal Irrigation
      - 4.4.4.2.5.1. Irrigation Pump/Transanal Irrigation market, 2018 - 2030 (USD Million and Volume Unit)
  - 4.4.4.3. Absorbent
    - 4.4.4.3.1. Absorbent market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.3.2. Underwear & Briefs
      - 4.4.4.3.2.1. Underwear & Briefs market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.3.3. Pads/Diapers
      - 4.4.4.3.3.1. Pads/Diapers market, 2018 - 2030 (USD Million and Volume Unit)
      - 4.4.4.3.3.2. Female
        
        4.4.4.3.3.2.1. Female market, 2018 - 2030 (USD Million and Volume Unit)
      - 4.4.4.3.3.3. Male
        
        4.4.4.3.3.3.1. Male market, 2018 - 2030 (USD Million and Volume Unit)
    - 4.4.4.3.4. Others
      - 4.4.4.3.4.1. Others market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 5. Continence Care Market: Segment Analysis, By Applications, 2018 - 2030 (USD Million)

5.1. Definition and Scope
5.2. Applications Market Share Analysis, 2024 & 2030
5.3. Global Continence Care Market, by Applications, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.4.1. Diabetes
  - 5.4.1.1. Diabetes market, 2018 - 2030 (USD Million)
- 5.4.2. Strokes
  - 5.4.2.1. Strokes market, 2018 - 2030 (USD Million)
- 5.4.3. BPH
  - 5.4.3.1. BPH market, 2018 - 2030 (USD Million)
- 5.4.4. Alzheimer
  - 5.4.4.1. Alzheimer market, 2018 - 2030 (USD Million)
- 5.4.5. Cerebral Palsy
  - 5.4.5.1. Cerebral Palsy market, 2018 - 2030 (USD Million)
- 5.4.6. Parkinson
  - 5.4.6.1. Parkinson market, 2018 - 2030 (USD Million)
- 5.4.7. Prostate Cancer
  - 5.4.7.1. Prostate Cancer market, 2018 - 2030 (USD Million)
- 5.4.8. Spinal Cord Injury
  - 5.4.8.1. Spinal Cord Injury market, 2018 - 2030 (USD Million)
- 5.4.9. Bladder Cancer
  - 5.4.9.1. Bladder Cancer market, 2018 - 2030 (USD Million)
- 5.4.10. Ovarian Cancer
  - 5.4.10.1. Ovarian Cancer market, 2018 - 2030 (USD Million)
- 5.4.11. Multiple Sclerosis
  - 5.4.11.1. Multiple Sclerosis market, 2018 - 2030 (USD Million)
- 5.4.12. Spina Bifida
  - 5.4.12.1. Spina Bifida market, 2018 - 2030 (USD Million)
- 5.4.13. Others
  - 5.4.13.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Continence Care Market: Segment Analysis, By Area of Incontinence, 2018 - 2030 (USD Million)

6.1. Definition and Scope
6.2. Area of Incontinence Market Share Analysis, 2024 & 2030
6.3. Global Continence Care Market, by Area of Incontinence, 2018 to 2030
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.4.1. Male
  - 6.4.1.1. Male market, 2018 - 2030 (USD Million)
  - 6.4.1.2. Stress Urinary Incontinence
    - 6.4.1.2.1. Stress Urinary Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.3. Urge/OAB (Overactive Bladder)
    - 6.4.1.3.1. Urge/OAB (Overactive Bladder) market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.4. Overflow
    - 6.4.1.4.1. Overflow market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.5. Functional
    - 6.4.1.5.1. Functional market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.6. Mixed
    - 6.4.1.6.1. Mixed market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.7. Reflex
    - 6.4.1.7.1. Reflex market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.1.8. Severe Incontinence
    - 6.4.1.8.1. Severe Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
- 6.4.2. Female
  - 6.4.2.1. Female market, 2018 - 2030 (USD Million)
  - 6.4.2.2. Stress Urinary Incontinence
    - 6.4.2.2.1. Stress Urinary Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.3. Urge/OAB (Overactive Bladder)
    - 6.4.2.3.1. Urge/OAB (Overactive Bladder) market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.4. Overflow
    - 6.4.2.4.1. Overflow market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.5. Functional
    - 6.4.2.5.1. Functional market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.6. Mixed
    - 6.4.2.6.1. Mixed market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.7. Reflex
    - 6.4.2.7.1. Reflex market, 2018 - 2030 (USD Million and Volume Unit)
  - 6.4.2.8. Severe Incontinence
    - 6.4.2.8.1. Severe Incontinence market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 7. Continence Care Market: Segment Analysis, By Bag Usage, 2018 - 2030 (USD Million)

7.1. Definition and Scope
7.2. Bag Usage Market Share Analysis, 2024 & 2030
7.3. Global Continence Care Market, by Bag Usage, 2018 to 2030
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 7.4.1. Sterile Bags
  - 7.4.1.1. Sterile Bags market, 2018 - 2030 (USD Million)
- 7.4.2. Non-sterile Bags
  - 7.4.2.1. Non-sterile Bags market, 2018 - 2030 (USD Million)

Chapter 8. Continence Care Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

8.1. Definition and Scope
8.2. End Use Market Share Analysis, 2024 & 2030
8.3. Global Continence Care Market, by End Use, 2018 to 2030
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 8.4.1. Home Care
  - 8.4.1.1. Home Care market, 2018 - 2030 (USD Million)
  - 8.4.1.2. Rehabilitation Centers
    - 8.4.1.2.1. Rehabilitation Centers market, 2018 - 2030 (USD Million and Volume Unit)
  - 8.4.1.3. Nursing Homes
    - 8.4.1.3.1. Nursing Homes market, 2018 - 2030 (USD Million and Volume Unit)
  - 8.4.1.4. Others
    - 8.4.1.4.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
- 8.4.2. Hospitals
  - 8.4.2.1. Hospitals market, 2018 - 2030 (USD Million)
- 8.4.3. Others
  - 8.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 9. Continence Care Market: Regional Estimates & Trend Analysis

9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
- 9.3.1. U.S.
  - 9.3.1.1. Key country dynamics
  - 9.3.1.2. Regulatory framework/ reimbursement structure
  - 9.3.1.3. Competitive scenario
  - 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.3.2. Canada
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. Regulatory framework/ reimbursement structure
  - 9.3.2.3. Competitive scenario
  - 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.4. Europe
- 9.4.1. UK
  - 9.4.1.1. Key country dynamics
  - 9.4.1.2. Regulatory framework/ reimbursement structure
  - 9.4.1.3. Competitive scenario
  - 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.2. Germany
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Regulatory framework/ reimbursement structure
  - 9.4.2.3. Competitive scenario
  - 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.3. France
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Regulatory framework/ reimbursement structure
  - 9.4.3.3. Competitive scenario
  - 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.4. Italy
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Regulatory framework/ reimbursement structure
  - 9.4.4.3. Competitive scenario
  - 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.5. Spain
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Regulatory framework/ reimbursement structure
  - 9.4.5.3. Competitive scenario
  - 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.6. Norway
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Regulatory framework/ reimbursement structure
  - 9.4.6.3. Competitive scenario
  - 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.7. Sweden
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. Regulatory framework/ reimbursement structure
  - 9.4.7.3. Competitive scenario
  - 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.8. Denmark
  - 9.4.8.1. Key country dynamics
  - 9.4.8.2. Regulatory framework/ reimbursement structure
  - 9.4.8.3. Competitive scenario
  - 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.9. Belgium
  - 9.4.9.1. Key country dynamics
  - 9.4.9.2. Regulatory framework/ reimbursement structure
  - 9.4.9.3. Competitive scenario
  - 9.4.9.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.10. Netherlands
  - 9.4.10.1. Key country dynamics
  - 9.4.10.2. Regulatory framework/ reimbursement structure
  - 9.4.10.3. Competitive scenario
  - 9.4.10.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.11. Ireland
  - 9.4.11.1. Key country dynamics
  - 9.4.11.2. Regulatory framework/ reimbursement structure
  - 9.4.11.3. Competitive scenario
  - 9.4.11.4. Ireland market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.12. Greece
  - 9.4.12.1. Key country dynamics
  - 9.4.12.2. Regulatory framework/ reimbursement structure
  - 9.4.12.3. Competitive scenario
  - 9.4.12.4. Greece market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.13. Poland
  - 9.4.13.1. Key country dynamics
  - 9.4.13.2. Regulatory framework/ reimbursement structure
  - 9.4.13.3. Competitive scenario
  - 9.4.13.4. Poland market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.14. Switzerland
  - 9.4.14.1. Key country dynamics
  - 9.4.14.2. Regulatory framework/ reimbursement structure
  - 9.4.14.3. Competitive scenario
  - 9.4.14.4. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.15. Austria
  - 9.4.15.1. Key country dynamics
  - 9.4.15.2. Regulatory framework/ reimbursement structure
  - 9.4.15.3. Competitive scenario
  - 9.4.15.4. Austriamarket estimates and forecasts 2018 to 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Japan
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/ reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2. China
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/ reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.3. India
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Regulatory framework/ reimbursement structure
  - 9.5.3.3. Competitive scenario
  - 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.4. Australia
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Regulatory framework/ reimbursement structure
  - 9.5.4.3. Competitive scenario
  - 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.5. South Korea
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Regulatory framework/ reimbursement structure
  - 9.5.5.3. Competitive scenario
  - 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Regulatory framework/ reimbursement structure
  - 9.5.6.3. Competitive scenario
  - 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Latin America
- 9.6.1. Brazil
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/ reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2. Mexico
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/ reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Regulatory framework/ reimbursement structure
  - 9.6.3.3. Competitive scenario
  - 9.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.4. Colombia
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Regulatory framework/ reimbursement structure
  - 9.6.4.3. Competitive scenario
  - 9.6.4.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
9.7. MEA
- 9.7.1. South Africa
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/ reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2. Saudi Arabia
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/ reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3. UAE
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/ reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4. Kuwait
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/ reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Recent Developments & Impact Analysis by Key Market Participants
10.3. Company Market Share Analysis, 2024
10.4. Key Company Profiles
- 10.4.1. Coloplast Group
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. B. Braun SE
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. Hollister Incorporated
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. ConvaTec Group Plc
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. BD (Becton, Dickinson and Company)
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Wellspect HealthCare
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Salts Healthcare Ltd.
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product benchmarking
  - 10.4.7.4. Strategic initiatives
- 10.4.8. Welland Medical Ltd.
  - 10.4.8.1. Company overview
  - 10.4.8.2. Financial performance
  - 10.4.8.3. Product benchmarking
  - 10.4.8.4. Strategic initiatives
- 10.4.9. Essity Aktiebolag
  - 10.4.9.1. Company overview
  - 10.4.9.2. Financial performance
  - 10.4.9.3. Product benchmarking
  - 10.4.9.4. Strategic initiatives

한글목차

요실금 관리 시장 성장과 동향

요실금 관리 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 요실금 관리 변수, 동향, 범위

제4장 요실금 관리 시장 : 부문 분석, 제품별, 2018-2030년(100만 달러와 수량 단위)

제5장 요실금 관리 시장 : 부문 분석, 용도별, 2018-2030년(100만 달러)

제6장 요실금 관리 시장 : 요실금 부위별 부문 분석, 2018-2030년(100만 달러)

제7장 요실금 관리 시장 : 백 용도별 부문 분석, 2018-2030년(100만 달러)

제8장 요실금 관리 시장 : 부문 분석, 최종 용도별, 2018-2030년(100만 달러)

제9장 요실금 관리 시장 : 지역별, 추정·동향 분석